https://www.selleckchem.com/products/oltipraz.html
for post-remission therapy than conventional chemotherapy, especially for those having a poor response to induction therapy.Post-transplant lymphoproliferative disorder (PTLD) is an aggressive malignancy that occurs in patients who have undergone solid organ transplantation or hematopoietic stem cell transplantation. It develops as the result of uncontrolled cell proliferations owing to reduced immunological surveillance. PTLD may occur with a various spectrum of clinical presentations, including both localized and extensive disease. M
Like
Comment
Share
